1. Outcomes in adults with congenital heart disease and heterotaxy syndrome: A single‐center experience
- Author
-
Keila N. Lopez, Christopher R. Broda, Douglas Moodie, Heather A. Dickerson, Peter R. Ermis, and Katherine B. Salciccioli
- Subjects
Adult ,Heart Defects, Congenital ,Cardiac Catheterization ,Pediatrics ,medicine.medical_specialty ,Asplenia ,Time Factors ,Heart disease ,Health Status ,Population ,Comorbidity ,Heterotaxy Syndrome ,030204 cardiovascular system & hematology ,Single Center ,Article ,Fontan circulation ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Cause of Death ,030225 pediatrics ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Survivors ,Cardiac Surgical Procedures ,education ,Retrospective Studies ,education.field_of_study ,business.industry ,Age Factors ,General Medicine ,Middle Aged ,medicine.disease ,Texas ,Progression-Free Survival ,medicine.anatomical_structure ,Ventricle ,Pediatrics, Perinatology and Child Health ,Disease Progression ,Surgery ,Polysplenia ,Cardiology and Cardiovascular Medicine ,business - Abstract
BACKGROUND: Heterotaxy syndrome is a condition in which the thoracoabdominal organs demonstrate abnormal lateral arrangement and is often associated with congenital heart disease. Little is known about the adult heterotaxy syndrome population with congenital heart disease (CHD). OBJECTIVE: Describe the outcomes and sociodemographics of the adult CHD population with heterotaxy syndrome. METHODS: Records of patients 18 years of age or older with diagnoses of both congenital heart disease and heterotaxy syndrome at Texas Children’s Hospital from 1964–2018 were reviewed. RESULTS: Sixty-two patients met inclusion criteria. Median age was 22.7 [IQR 19.6–30.0] years; 26 (42%) were female; and 13 (21%) of patients had a gap in care of >3 years. Median follow-up time in adulthood was 2.9 [IQR 1.3–8.2] years. Forty-three (69%) of patients had single ventricle heart disease, 31 (71%) of whom completed Fontan circulation. A total of 36 interventions occurred in 24 patients which included 16 cardiac catherization interventions, 13 electrophysiology related procedures and 18 surgical procedures including 2 orthotopic heart transplants. The median age for death or heart transplant was 45.3 (95%CI 34.3–56.1) years. Heart failure-free survival was 80.8 ± 5.2%, 58.7 ± 11.0% and 31.1 ± 15.7% at 20, 30 and 40 years old. Cerebrovascular accident-free survival was 84.3 ± 5.1%, 54.2 ± 11.3%, and 40.6 ± 14.5% at 20, 30 and 40 years old. Tachyarrhythmia-free survival was 54.0 ± 7.1%, 29.2 ± 8.3%, and 19.5 ± 9.7% at 20, 30 and 40 years old and bradyarrhythmia-free survival was 66.0 ± 6.3%, 41.7 ± 9.4%, and 33.4 ± 10.6% at ages 20, 30 and 40 years. CONCLUSIONS: At a tertiary referral center, adult patients with CHD and heterotaxy syndrome have high rates of comorbidities and early death or heart transplant. Longitudinal surveillance and further exploration into factors associated with improved survival in this population are warranted.
- Published
- 2019